XTNT (Xtant Medical Holdings) Cyclically Adjusted PB Ratio: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTNT Xtant Medical Holdings Inc XTNT
27 GF Score
Price $0.46
GF Value $0.62
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xtant Medical Holdings  (AMEX:XTNT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Xtant Medical Holdings Cyclically Adjusted PB Ratio Related Terms


Xtant Medical Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Cyclically Adjusted PB Ratio Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XTNT vs POSC, LUNG, MDAI: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted PB Ratio falls into.


XTNT
27GF Score
Xtant Medical Holdings Inc XTNT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Xtant Medical Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Xtant Medical Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.347/330.2130*330.2130
=0.347

Current CPI (Mar. 2026) = 330.2130.

Xtant Medical Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.446 241.018 -0.611
201609 -4.565 241.428 -6.244
201612 -4.881 241.432 -6.676
201703 -7.681 243.801 -10.403
201706 -14.008 244.955 -18.884
201709 -19.809 246.819 -26.502
201712 -38.441 246.524 -51.491
201803 1.184 249.554 1.567
201806 0.777 251.989 1.018
201809 0.954 252.439 1.248
201812 -3.299 251.233 -4.336
201903 -2.955 254.202 -3.839
201906 -3.098 256.143 -3.994
201909 -3.233 256.759 -4.158
201912 -3.334 256.974 -4.284
202003 -3.489 258.115 -4.464
202006 -3.518 257.797 -4.506
202009 -3.597 260.280 -4.563
202012 0.187 260.474 0.237
202103 0.385 264.877 0.480
202106 0.391 271.696 0.475
202109 0.376 274.310 0.453
202112 0.355 278.802 0.420
202203 0.335 287.504 0.385
202206 0.322 296.311 0.359
202209 0.321 296.808 0.357
202212 0.314 296.797 0.349
202303 0.300 301.836 0.328
202306 0.284 305.109 0.307
202309 0.421 307.789 0.452
202312 0.394 306.746 0.424
202403 0.366 312.332 0.387
202406 0.345 314.175 0.363
202409 0.330 315.301 0.346
202412 0.309 315.605 0.323
202503 0.315 319.799 0.325
202506 0.348 322.561 0.356
202509 0.360 324.800 0.366
202512 0.364 324.054 0.371
202603 0.347 330.213 0.347

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Xtant Medical Holdings (XTNT) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of $0.46 is trading 26% below its estimated GF Value™ of $0.62. GuruFocus considers Xtant Medical Holdings to be Modestly Undervalued.

Key valuation signals for XTNT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.62 vs. price of $0.46 (26% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the XTNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
27GF Score

Get the complete analysis for XTNT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.46
Price
$0.62
GF Value